Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV · Real-Time Price · USD
2.060
-0.090 (-4.19%)
Aug 28, 2026, 12:26 PM EDT - Market open
Acrivon Therapeutics Market Cap
Acrivon Therapeutics has a market cap or net worth of $88.28 million as of August 28, 2026. Its market cap has increased by 106.35% in one year.
Market Cap
88.28M
Enterprise Value
433.93K
1-Year Change
106.35%
Ranking
Category
Stock Price
$2.06
ChartMarket Cap Chart
Since the IPO on November 15, 2022, Acrivon Therapeutics's market cap has decreased from $235.12M to $88.28M, a decrease of -62.45%. That is a compound annual growth rate of -22.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 88.28M | 16.08% |
| Dec 31, 2025 | 76.05M | -59.43% |
| Dec 31, 2024 | 187.44M | 71.66% |
| Dec 29, 2023 | 109.20M | -54.61% |
| Dec 30, 2022 | 240.59M | 2.33% |
| Nov 15, 2022 | 235.12M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kalaris Therapeutics | 97.12M |
| Adicet Bio | 96.34M |
| Atara Biotherapeutics | 94.15M |
| Aldeyra Therapeutics | 94.11M |
| Fortress Biotech | 93.72M |
| ImmuCell | 91.00M |
| Dogwood Therapeutics | 90.42M |
| Rallybio | 89.64M |